C4 Therapeutics, Inc.CCCCNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-98.69M
↓ 60% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-61.53M
Historical baseline
PeriodValueYoY Change
2025$-98.69M-51.5%
2024$-65.16M+39.0%
2023$-106.84M-0.8%
2022$-105.94M-21.8%
2021$-86.97M-29.3%
2020$-67.25M-220.9%
2019$55.61M+427.5%
2018$-16.98M-